Trials / Not Yet Recruiting
Not Yet RecruitingNCT06914427
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a study using a parallel control approach and is expected to recruit 35 volunteers, including 8 prostate cancer patients, 8 neuroendocrine tumour patients, 8 glioma patients, 8 Parkinson's syndrome patients, and 3 normal volunteers, to undergo dual-nuclide PET/CT imaging and to validate the isolation effect and quantitative accuracy of simultaneous dual-nuclide imaging in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET/CT | Scanning time: acquisition starts 60±10 minutes after 68Ga/18F probe injection; 10-20 minutes after 11C-MET injection; 60 minutes after 11C-CFT injection; Scanning parameters: whole-body imaging (cranial vault to mid-thigh), routine single-nuclide 3 min/bed; dual-nuclide 5-10 min/bed. |
Timeline
- Start date
- 2025-03-28
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2025-04-06
- Last updated
- 2025-04-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06914427. Inclusion in this directory is not an endorsement.